Study Data
| Project uploaded by: | Amrita |
| Project ID: | IMP_100034 |
| Title: | Understanding Metabolic Alterations in Advanced Stage Chronic Kidney Disease Patients by NMR-based metabolomics |
| Project Description: | Understanding metabolic alterations in CKD is crucial, as serum creatinine-based diagnosis lacks precision, affecting key clinical decisions. In this study, a 1 H NMR-based metabolomics approach was employed to distinguish between advanced-stage CKD (ASCKD) patients and healthy controls (HC), as well as within the ASCKD stages (Stage 4 and Stage 5). Serum samples from 52 ASCKD (S4, S5) and 25 HC were analyzed. Multivariate and univariate analysis revealed distinct metabolic patterns across groups, providing insights into CKD pathophysiology and associated pathway alterations. Compared to HC, six metabolites were significantly altered in both stage 4 and 5 CKD patients with upregulated creatinine, urea, myoinositol, choline, N, N-dimethylglycine, and downregulated tyrosine, showing potential as biomarkers with AUC above 0.8 in ROC analysis. Additionally, myo-inositol, dimethylamine, N, N-dimethylglycine, and choline correlate positively with creatinine while tyrosine correlates negatively. Amino acid metabolism was downregulated in S5 indicating more severity. Within ASCKD patients, significant alterations were observed in metabolites such as glutamate, glutamine, alanine, threonine, myo-inositol, dimethylamine, citrulline, urea, citrate, and betaine. Pathway analysis identified five distinct metabolic pathways associated with CKD progression. Consequently, we propose a panel of serum metabolites which should be monitored along with creatinine for following CKD progression. Markers of oxidative stress, inflammation, and gut dysbiosis were evident in the perturbed metabolic profile due to the systemic impact of CKD. |
| Research Area: | Biological Sciences |
| Funding Source: | NA |
| Project Contributors: | Amrita Sahu 1,2 , Upasna Gupta 1,2 , Bikash Baishya 1,2 *, Dharmendra Singh Bhadauria 3 *, Neeraj Sinha 1, 2 |
| Sr.No | Sample ID | Sample Name | Organism | Source | Sample Preparation Protocol | Sample Type | Experimental Condition | Time of treatment | Variant/Variety | Gender | Age | Replicates | Storage Conditions | Extraction Protocol | Number of files per sample |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMSM_101442 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 2 | IMSM_101443 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 3 | IMSM_101444 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 4 | IMSM_101445 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 5 | IMSM_101446 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 6 | IMSM_101447 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 7 | IMSM_101448 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 8 | IMSM_101449 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 9 | IMSM_101450 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 10 | IMSM_101451 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 11 | IMSM_101452 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 12 | IMSM_101453 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 13 | IMSM_101454 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 14 | IMSM_101455 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 15 | IMSM_101456 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 16 | IMSM_101457 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 17 | IMSM_101458 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 18 | IMSM_101459 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 19 | IMSM_101460 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 20 | IMSM_101461 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 21 | IMSM_101462 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 22 | IMSM_101463 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 23 | IMSM_101464 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 24 | IMSM_101465 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 25 | IMSM_101466 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 26 | IMSM_101467 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 27 | IMSM_101468 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 28 | IMSM_101469 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 29 | IMSM_101470 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 30 | IMSM_101471 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 31 | IMSM_101472 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 32 | IMSM_101473 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 33 | IMSM_101474 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 34 | IMSM_101475 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 35 | IMSM_101476 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 36 | IMSM_101477 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 37 | IMSM_101478 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 38 | IMSM_101479 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 39 | IMSM_101480 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 40 | IMSM_101481 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 41 | IMSM_101482 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 42 | IMSM_101483 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 43 | IMSM_101484 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 44 | IMSM_101485 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 45 | IMSM_101486 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 46 | IMSM_101487 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 47 | IMSM_101488 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 48 | IMSM_101489 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 49 | IMSM_101490 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 50 | IMSM_101491 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 51 | IMSM_101492 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 52 | IMSM_101493 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 53 | IMSM_101494 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 54 | IMSM_101495 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 55 | IMSM_101496 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 56 | IMSM_101497 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 57 | IMSM_101498 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 58 | IMSM_101499 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 59 | IMSM_101500 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 60 | IMSM_101501 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 61 | IMSM_101502 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 62 | IMSM_101503 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 63 | IMSM_101504 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 64 | IMSM_101505 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 65 | IMSM_101506 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 66 | IMSM_101507 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 67 | IMSM_101508 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 68 | IMSM_101509 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 69 | IMSM_101510 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 70 | IMSM_101511 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 71 | IMSM_101512 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 72 | IMSM_101513 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 73 | IMSM_101514 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 74 | IMSM_101515 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 75 | IMSM_101516 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 76 | IMSM_101517 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 77 | IMSM_101518 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
| Sr.No | NMR Exp ID | Sample Name/ID | Reference Standard | NMR Instrument Name | NMR Instrument Type | NMR Experiment Type | NMR Spectrometer Frequency | NMR Probe | NMR Probe temperature | NMR Solvent | NMR tube size | Data Transformation (Software/s Used) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IME_100687 | Human Blood / IMSM_101442 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 2 | IME_100688 | Human Blood / IMSM_101443 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 3 | IME_100689 | Human Blood / IMSM_101444 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 4 | IME_100690 | Human Blood / IMSM_101445 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 5 | IME_100691 | Human Blood / IMSM_101446 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 6 | IME_100692 | Human Blood / IMSM_101447 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 7 | IME_100693 | Human Blood / IMSM_101448 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 8 | IME_100694 | Human Blood / IMSM_101449 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 9 | IME_100695 | Human Blood / IMSM_101450 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 10 | IME_100696 | Human Blood / IMSM_101451 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 11 | IME_100697 | Human Blood / IMSM_101452 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 12 | IME_100698 | Human Blood / IMSM_101453 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 13 | IME_100699 | Human Blood / IMSM_101454 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 14 | IME_100700 | Human Blood / IMSM_101455 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 15 | IME_100701 | Human Blood / IMSM_101456 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 16 | IME_100702 | Human Blood / IMSM_101457 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 17 | IME_100703 | Human Blood / IMSM_101458 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 18 | IME_100704 | Human Blood / IMSM_101459 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 19 | IME_100705 | Human Blood / IMSM_101460 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 20 | IME_100706 | Human Blood / IMSM_101461 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 21 | IME_100707 | Human Blood / IMSM_101462 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 22 | IME_100708 | Human Blood / IMSM_101463 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 23 | IME_100709 | Human Blood / IMSM_101464 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 24 | IME_100710 | Human Blood / IMSM_101465 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 25 | IME_100711 | Human Blood / IMSM_101466 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 26 | IME_100712 | Human Blood / IMSM_101467 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 27 | IME_100713 | Human Blood / IMSM_101468 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 28 | IME_100714 | Human Blood / IMSM_101469 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 29 | IME_100715 | Human Blood / IMSM_101470 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 30 | IME_100716 | Human Blood / IMSM_101471 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 31 | IME_100717 | Human Blood / IMSM_101472 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 32 | IME_100718 | Human Blood / IMSM_101473 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 33 | IME_100719 | Human Blood / IMSM_101474 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 34 | IME_100720 | Human Blood / IMSM_101475 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 35 | IME_100721 | Human Blood / IMSM_101476 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 36 | IME_100722 | Human Blood / IMSM_101477 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 37 | IME_100723 | Human Blood / IMSM_101478 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 38 | IME_100724 | Human Blood / IMSM_101479 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 39 | IME_100725 | Human Blood / IMSM_101480 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 40 | IME_100726 | Human Blood / IMSM_101481 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 41 | IME_100727 | Human Blood / IMSM_101482 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 42 | IME_100728 | Human Blood / IMSM_101483 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 43 | IME_100729 | Human Blood / IMSM_101484 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 44 | IME_100730 | Human Blood / IMSM_101485 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 45 | IME_100731 | Human Blood / IMSM_101486 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 46 | IME_100732 | Human Blood / IMSM_101487 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 47 | IME_100733 | Human Blood / IMSM_101488 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 48 | IME_100734 | Human Blood / IMSM_101489 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 49 | IME_100735 | Human Blood / IMSM_101490 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 50 | IME_100736 | Human Blood / IMSM_101491 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 51 | IME_100737 | Human Blood / IMSM_101492 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 52 | IME_100738 | Human Blood / IMSM_101493 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 53 | IME_100739 | Human Blood / IMSM_101494 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 54 | IME_100740 | Human Blood / IMSM_101495 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 55 | IME_100741 | Human Blood / IMSM_101496 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 56 | IME_100742 | Human Blood / IMSM_101497 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 57 | IME_100743 | Human Blood / IMSM_101498 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 58 | IME_100744 | Human Blood / IMSM_101499 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 59 | IME_100745 | Human Blood / IMSM_101500 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 60 | IME_100746 | Human Blood / IMSM_101501 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 61 | IME_100747 | Human Blood / IMSM_101502 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 62 | IME_100748 | Human Blood / IMSM_101503 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 63 | IME_100749 | Human Blood / IMSM_101504 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 64 | IME_100750 | Human Blood / IMSM_101505 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 65 | IME_100751 | Human Blood / IMSM_101506 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 66 | IME_100752 | Human Blood / IMSM_101507 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 67 | IME_100753 | Human Blood / IMSM_101508 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 68 | IME_100754 | Human Blood / IMSM_101509 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 69 | IME_100755 | Human Blood / IMSM_101510 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 70 | IME_100756 | Human Blood / IMSM_101511 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 71 | IME_100757 | Human Blood / IMSM_101512 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 72 | IME_100758 | Human Blood / IMSM_101513 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 73 | IME_100759 | Human Blood / IMSM_101514 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 74 | IME_100760 | Human Blood / IMSM_101515 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 75 | IME_100761 | Human Blood / IMSM_101516 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 76 | IME_100762 | Human Blood / IMSM_101517 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 77 | IME_100763 | Human Blood / IMSM_101518 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| Sr.No | First name | Last name | Organization | Designation | |
|---|---|---|---|---|---|
| 1 | Dr. Neeraj | Sinha | neerajcbmr@gmail.com | Centre of Biomedical Research | co_principal_investigator |
| 2 | Dr. Dharmendra | Bhadauriaria | docdharm10@gmail.com | Sanjay Gandhi Postgraduate institute of medical science | principal_investigator |
| 3 | Dr.Bikash | Baishya | bikash2baishya@gmail.com | Centre of Biomedical Research | principal_investigator |
| 4 | Upasna | Gupta | upasnagupta941@gmail.com | Centre of Biomedical Research | research_scholar |
| 5 | Amrita | Sahu | sahuamrita456@gmail.com | Centre of Biomedical Research | research_scholar |
| Sr.No | ftprun ID | NMR Exp ID | NMR Data Files |
|---|---|---|---|
| 1 | IMR_101286 | IME_100687 | 190.zip |
| 2 | IMR_101287 | IME_100688 | 191.zip |
| 3 | IMR_101288 | IME_100689 | 192.zip |
| 4 | IMR_101289 | IME_100690 | 193.zip |
| 5 | IMR_101290 | IME_100691 | 194.zip |
| 6 | IMR_101291 | IME_100692 | 195.zip |
| 7 | IMR_101292 | IME_100693 | 196.zip |
| 8 | IMR_101293 | IME_100694 | 197.zip |
| 9 | IMR_101294 | IME_100695 | 198.zip |
| 10 | IMR_101295 | IME_100696 | 199.zip |
| 11 | IMR_101296 | IME_100697 | 200.zip |
| 12 | IMR_101297 | IME_100698 | 201.zip |
| 13 | IMR_101298 | IME_100699 | 202.zip |
| 14 | IMR_101299 | IME_100700 | 203.zip |
| 15 | IMR_101300 | IME_100701 | 204.zip |
| 16 | IMR_101301 | IME_100702 | 205.zip |
| 17 | IMR_101302 | IME_100703 | 206.zip |
| 18 | IMR_101303 | IME_100704 | 207.zip |
| 19 | IMR_101304 | IME_100705 | 208.zip |
| 20 | IMR_101305 | IME_100706 | 209.zip |
| 21 | IMR_101306 | IME_100707 | 210.zip |
| 22 | IMR_101307 | IME_100708 | 211.zip |
| 23 | IMR_101308 | IME_100709 | 212.zip |
| 24 | IMR_101309 | IME_100710 | 182.zip |
| 25 | IMR_101310 | IME_100711 | 183.zip |
| 26 | IMR_101311 | IME_100712 | 184.zip |
| 27 | IMR_101312 | IME_100713 | 185.zip |
| 28 | IMR_101313 | IME_100714 | 186.zip |
| 29 | IMR_101314 | IME_100715 | 187.zip |
| 30 | IMR_101315 | IME_100716 | 188.zip |
| 31 | IMR_101316 | IME_100717 | 189.zip |
| 32 | IMR_101317 | IME_100718 | 315.zip |
| 33 | IMR_101318 | IME_100719 | 317.zip |
| 34 | IMR_101319 | IME_100720 | 321.zip |
| 35 | IMR_101320 | IME_100721 | 323.zip |
| 36 | IMR_101321 | IME_100722 | 325.zip |
| 37 | IMR_101322 | IME_100723 | 358.zip |
| 38 | IMR_101323 | IME_100724 | 360.zip |
| 39 | IMR_101324 | IME_100725 | 362.zip |
| 40 | IMR_101325 | IME_100726 | 364.zip |
| 41 | IMR_101326 | IME_100727 | 366.zip |
| 42 | IMR_101327 | IME_100728 | 367.zip |
| 43 | IMR_101328 | IME_100729 | 398.zip |
| 44 | IMR_101329 | IME_100730 | 407.zip |
| 45 | IMR_101330 | IME_100731 | 408.zip |
| 46 | IMR_101331 | IME_100732 | 409.zip |
| 47 | IMR_101332 | IME_100733 | 410.zip |
| 48 | IMR_101333 | IME_100734 | 411.zip |
| 49 | IMR_101334 | IME_100735 | 412.zip |
| 50 | IMR_101335 | IME_100736 | 413.zip |
| 51 | IMR_101336 | IME_100737 | 414.zip |
| 52 | IMR_101337 | IME_100738 | 415.zip |
| 53 | IMR_101338 | IME_100739 | 416.zip |
| 54 | IMR_101339 | IME_100740 | 417.zip |
| 55 | IMR_101340 | IME_100741 | 418.zip |
| 56 | IMR_101341 | IME_100742 | 419.zip |
| 57 | IMR_101342 | IME_100743 | 1.zip |
| 58 | IMR_101343 | IME_100744 | 3.zip |
| 59 | IMR_101344 | IME_100745 | 5.zip |
| 60 | IMR_101345 | IME_100746 | 7.zip |
| 61 | IMR_101346 | IME_100747 | 9.zip |
| 62 | IMR_101347 | IME_100748 | 11.zip |
| 63 | IMR_101348 | IME_100749 | 15.zip |
| 64 | IMR_101349 | IME_100750 | 20.zip |
| 65 | IMR_101350 | IME_100751 | 22.zip |
| 66 | IMR_101351 | IME_100752 | 24.zip |
| 67 | IMR_101352 | IME_100753 | 26.zip |
| 68 | IMR_101353 | IME_100754 | 31.zip |
| 69 | IMR_101354 | IME_100755 | 33.zip |
| 70 | IMR_101355 | IME_100756 | 35.zip |
| 71 | IMR_101356 | IME_100757 | 36.zip |
| 72 | IMR_101357 | IME_100758 | 37.zip |
| 73 | IMR_101358 | IME_100759 | 38.zip |
| 74 | IMR_101359 | IME_100760 | 39.zip |
| 75 | IMR_101360 | IME_100761 | 40.zip |
| 76 | IMR_101361 | IME_100762 | 41.zip |
| 77 | IMR_101362 | IME_100763 | 42.zip |
Download Metabolite/Compound
| Sr.No | Structure | Details |
|---|